Company Profile>
Group leader>
Development History>
Drug products>
APIs and Intermediates>
Veterinary drugs>
R&D system>
Intellectual property system>
Production quality system>
News Information>
Media attention>
Stock information>
Company Announcement>
Interactive communication>
Talent concept>
Company Activity>
Social recruitment>
OA system>
Enterprise mailbox>
Electronic collaboration>
Name:Everolimus(2.0% BHT & 2.5%-3.0% BHT)
CAS No.:159351-69-6
状态:DMF No. : 032020
分类:抗肿瘤